Cargando…
The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer
Pancreatic ductal adenocarcinomas are strongly resistant to chemotherapeutic drugs and radiation, underscoring the need for new therapeutic targets, particularly ones which target the numerous out of cycle cancer cells. Analysis of resected tumors for nuclear Ki67 antigen has shown that about 70% of...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837318/ https://www.ncbi.nlm.nih.gov/pubmed/24281169 http://dx.doi.org/10.3390/cancers2031492 |